Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Induction Chemotherapy Followed by Chemoradiotherapy and Surgery in Esophageal Cancer
NCT02924909Phase 2Unknown
- Sponsor
- Instituto Nacional de Câncer José Alencar Gomes da Silva
- Start
- Feb 2017
- Primary completion
- Sep 2020
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of carboplatin, paclitaxel in esophageal cancer, gastroesophageal junction cancer, sponsored by Instituto Nacional de Câncer José Alencar Gomes da Silva. Status: unknown.
02
Drugs
carboplatinpaclitaxel
03
Conditions
esophageal cancergastroesophageal junction cancer
Beyond the preview
Go deeper on NCT02924909.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02924909.